Type 2 Diabetes, Chronic Kidney Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Type 2 Diabetes, Chronic Kidney Disease trials may be worth asking about

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 33 trials

RecruitingNot Applicable

NCT07554469

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chroni…

This is a prospective observational study in which data from people with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) who will be receivin…

Spain500 participantsStarted 2026-05-26Updated 2026-06-29

Treatment: Finerenone (Kerendia, BAY94-8862)

RecruitingPhase 4

NCT07017270

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

This study aims to determine if GLP1RA is safe and tolerable in maintenance dialysis population, adherence, and feasibility of a larger definitive cardiovascula…

Canada100 participantsStarted 2025-11-27Updated 2026-06-26

Treatment: Semaglutide Pen

RecruitingPhase 2

NCT07271186

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidn…

This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidne…

United States270 participantsStarted 2026-01-09Updated 2026-06-26

Treatment: ALN-ANG3, Evinacumab

RecruitingNot Applicable

NCT06278207

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is a…

This is an observational study, in which data from people in Asia and in the United States with chronic kidney disease (CKD) together with type 2 diabetes (T2D)…

United States, Germany +2 more50,000 participantsStarted 2024-05-15Updated 2026-06-18

Treatment: Finerenone (BAY 94-8862)

RecruitingNot Applicable

NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type…

United States420 participantsStarted 2025-10-28Updated 2026-06-16

Treatment: (IRIS-CKD Management Program): Education, (IRIS-CKD Management Program): GDMT

RecruitingNot Applicable

NCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the…

United States750 participantsStarted 2025-10-28Updated 2026-06-16

Treatment: (IRIS-CKD Screening Program): Home Kit, (IRIS-CKD Screening Program): Standard Lab Order

All recent trials (100 shown)

CompletedNot Applicable

NCT07672639

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidn…

This multicenter retrospective observational study aims to develop and validate an interpretable machine learning model for differentiating diabetic kidney dise…

China2,201 participantsStarted 2019-01-01Updated 2026-06-29

By InvitationNot Applicable

NCT07673822

Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

This study tests the prevalence and characteristics of overlapping obesity, type 2 diabetes (T2D), cardiovascular disease (CVD), chronic kidney disease (CKD), a…

South Korea800,000 participantsStarted 2026-06-08Updated 2026-06-29

Type 2 Diabetes, Chronic Kidney Disease

Trial phase breakdown

Trial status

Actively recruiting — 33 trials

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chroni…

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidn…

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is a…

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

All recent trials (100 shown)

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidn…

Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

Trial phase breakdown

Trial status

Actively recruiting — 33 trials

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chroni…

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidn…

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is a…

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

All recent trials (100 shown)

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidn…

Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and…

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia…

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIU…

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Ki…

Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Dise…

RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"

Home-based Interventions for FrAilty preveNTion in AdultS With DIabeTes and Chronic Kidney Disease

Sweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic Groups

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without…

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 D…

Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabete…